The team

Department of Medicinal Chemistry

IICIMED

The department of Medicinal Chemistry is involved in Drug Discovery, i.e. the design, synthesis, purification, structural elucidation and study of structure-activity relationships of original heterocyclic molecules as antifungal, antiparasitic and antibacterial drug candidates. The physicochemical and ADME-Tox properties of compounds of biological interest are also discussed in all the projects.

Département de Chimie Thérapeutique | IICIMED

Teacher-researchers

Marchand, P. | IICIMED
Pascal MARCHAND

Professor - Head of Department

Bazin, M.-A. | IICIMED
Marc-Antoine BAZIN

Associate Professor

Duflos, M. | IICIMED
Muriel DUFLOS

Professor

Logé, C. | IICIMED
Cédric LOGÉ

Associate Professor

Ambeu, C. | IICIMED
Christelle AMBEU

Visiting Scientist

Yvorra, T. | IICIMED
Thomas YVORRA

Attaché Temporaire d'Enseignement et de Recherche

Technical staff

Post-doctoral researcher

IICIMED

Other departments


Département Résistances Bactériennes | IICIMED
Department of Bacterial Resistances

The Department of Bacterial Resistances studies how interactions between the host, its microbiota and drugs (particularly anti-infective drugs, but not exclusively) influence bacterial resistance to antibiotics. We are working in particular on digestive colonisation by multi-resistant Enterobacteriaceae, and are testing the possibility of treating this colonisation with live bacteria ('probiotics') or polysaccharides ('prebiotics'). We are also working on improving the use of antibiotics, with the aim of ensuring effective treatment of bacterial infections (particularly pneumonia and community-acquired urinary tract infections) while minimising the risk of emergence, persistence and spread of multi-resistant bacteria.

Département de Mycologie Médicale et Parasitologie | IICIMED
Department of Medical Mycology and Parasitology

The Department of Medical Mycology and Parasitology is supported by university and hospital-university staff, enabling it to focus on health-related issues. Research strategies benefit from expertise in cell culture, signalling, molecular biology, immunology applied to microbiology, recombinant protein production (P2R platform) and in vivo models. Its activities focus mainly on resistance issues and the discovery of new therapeutic targets.